CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 150 enrolled
Drug / intervention
Intra muscular Midazolam +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06271096
NCT06271096Early Ph 1Completed
CompareCT.gov

Intramuscular Midazolam Versus Intravenous Diazepam for Acute Seizure in Children

Arooj Khan·interventional·Posted Feb 21, 2024·Updated Feb 23, 2024

In Brief

A Early Phase 1 clinical trial evaluating Intra muscular Midazolam and Intravascular Diazepam for Seizures. Completed, enrolled 150 participants across 1 site.

Detailed Summary

IM-midazolam in acute seizures, whenever IV cannulation is not possible. It is easy to administer and can be used in prehospital settings as IV cannulation requires experience, especially in pediatric age group. Moreover, the transit time to the hospital can be prolonged in our areas which can delay the treatment if intravenous cannulation is considered. More studies are required to assess the feasibility of administering IM-midazolam in a prehospital setting to control acute seizures

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSeizures
CountriesPakistan
Collaborators--

Timeline

Early Ph 1CompletedFinished
2020202120222023202420252026
First PostedFeb 21, 2024
Enrollment StartNov 1, 2019
Primary CompletionNov 1, 2022
Study CompletionJan 1, 2024
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 2.4 years ago

Interventions

Intra muscular Midazolamdrug

ROUTE OF ADMINISTRATION AND DRUG EFFICACY COMPARED

Intravascular Diazepamdrug

ROUTE OF ADMINISTRATION AND DRUG EFFICACY COMPARED